Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protalix BioTherapeutics, Inc. | Director | Stock Option (Right to Buy) | 61.7K | Sep 29, 2023 | Direct | ||
Vascular Biogenics Ltd. | Director | Ordinary Shares | 60K | Jan 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PLX | Protalix BioTherapeutics, Inc. | Sep 29, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
VBLT | Vascular Biogenics Ltd. | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | Director |
PLX | Protalix BioTherapeutics, Inc. | Sep 7, 2022 | 1 | $0 | 4 | Sep 9, 2022 | Director |
PLX | Protalix BioTherapeutics, Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
PLX | Protalix BioTherapeutics, Inc. | Jun 30, 2022 | 0 | $0 | 3 | Jul 5, 2022 | Director |